No Data
Investors Don't See Light At End Of Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Tunnel And Push Stock Down 26%
Further Weakness as Shanghai Xuerong BiotechnologyLtd (SZSE:300511) Drops 16% This Week, Taking Three-year Losses to 47%
shanghai xuerong bio-technology (300511.SZ): It is planned to extend the "annual output of 0.12 million tons of edible fungi modern agriculture industrial park project" to December 31, 2026.
Shanghai Xuerong Bio-Technology (300511.SZ) announced that on November 29, 2024, the company held the 18th meeting of the fifth board of directors and the 11th meeting of the fifth board of supervisors, deliberating and passing the resolution on the extension of the date for the 'Annual output of 0.12 million tons of edible fungus modern agriculture industrial park project' to reach the designated available state until December 31, 2026. This proposal does not involve changes in the use of funds raised and does not require approval by the company's shareholders' meeting.
Xuerong Biology: Report for the third quarter of 2024
shanghai xuerong bio-technology (300511.SZ): The controlling shareholder, director, and general manager Yang Yongping have been released from detention.
shanghai xuerong bio-technology (300511.SZ) announced on June 11, 2024, that the company disclosed "Regarding the company's controlling...
Shanghai Xuerong Biotechnology Co.,Ltd. (SZSE:300511) Surges 36% Yet Its Low P/S Is No Reason For Excitement
Revenues Working Against Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Share Price Following 26% Dive